The intrapleural administration with thymic peptides in malignant pleural effusion: A clustered systematic review and meta-analysis

被引:1
作者
Wang, Cheng-Qiong [1 ,2 ]
Shen, You-Shu [4 ]
Chen, Xiao-Fan [3 ]
Jiang, Hong [1 ,2 ]
Yang, Xue-Mei [1 ,2 ]
Fan, Teng-Yang [2 ]
Li, Shu-Guang [2 ]
Yang, Ping [4 ]
Zhan, Lin [5 ]
Chen, Rong [6 ]
Feng, Ji-Hong [7 ]
Xiao, Xue [1 ,2 ]
Xiao, Zheng [1 ,2 ]
机构
[1] Zunyi Med Coll, Affiliated Hosp, Evidence Based Med Ctr, MOE Virtual Res Ctr Evidence Based Med, Zunyi 563003, Guizhou, Peoples R China
[2] Zunyi Med Univ, Dept Gen Practice, Affiliated Hosp, Zunyi 563003, Guizhou, Peoples R China
[3] Jiangxi Univ Tradit Chinese Med, Evidence Based Med Res Ctr, Nanchang 330004, Jiangxi, Peoples R China
[4] Zunyi Med Univ, Dept Infect Dis, Affiliated Hosp, Zunyi 563003, Guizhou, Peoples R China
[5] Guizhou Univ, Guizhou Prov Peoples Hosp, Lab Res Ctr, Guiyang 550002, Guizhou, Peoples R China
[6] Anshun Peoples Hosp, Dept Infect Dis, Anshun 561000, Guizhou, Peoples R China
[7] Wenzhou Med Univ, Lishui Peoples Hosp, Dept Oncol, Affiliated Hosp 6, Lishui, Zhejiang, Peoples R China
关键词
Malignant pleural effusion (MPE); Thymic peptides (TPs); Intrapleural administration; Chemical agents; Clustered systematic review; Meta-analysis; MANAGEMENT; CANCER; BLEOMYCIN;
D O I
10.1016/j.intimp.2022.108688
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Thymic peptides (TPs) are often used to control malignant pleural effusion (MPE). So, we performed a clustered systematic review and meta-analysis to clarify the treatment regimens of TPs for MPE, demonstrate their clinical effectiveness and safety, and reveal the indications and optimal usage for a desired effectiveness. Materials and methods: We collected all trials of TPs for MPE from Chinese and English databases (from inception until May 2021). After evaluating their bias risk, we pooled the data from each regimen using the meta-analysis or descriptive analysis, and summarized the evidence quality using the Grading of Recommendation Assessment, Development and Evaluation approach (GRADE). Results: Thirty-four trials were clustered into TPs for MPE from lung cancer or miscellaneous tumors. The TPs combined with chemical agents were mainly used in MPE from lung cancer. All five regimens, only thymosin with oxaliplatin (L-OHP) significantly improved the complete response (CR) [2.40 (1.84 to 3.13)], quality of life [2.04 (1.20 to 3.48)], 0.5- and 1-year overall survival (OS) rate [5.75 (3.02 to 10.92) and 5.29, (1.71 to 16.36)]. It also up-regulated the T lymphocyte levels, and reduced the pleurodesis failure, disease progression and adverse events. In patients with moderate to large volume, Karnofsky Performance Status score >= 50 or anticipated survival time >= 3 months, the thymosin (300 mg/time, one time/week and lasting two to eight times) with oxaliplatin (100 mg/m(2)) achieved a desired response. Most results were moderate quality. Conclusions: The current evidences indicate that the TPs are important pleurodesis agents, which combination with chemical agents are mainly used in MPE from lung cancer. The thymosin with L-OHP is a main regimen, which shows a significant improvement in clinical responses, antitumor immunity, and with a reasonable security. The evidence also provides indications and optimal usage for achieving a desired effectiveness.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] Safety and efficacy of Kanglaite injection in the treatment of malignant pleural effusion: a meta-analysis
    Chen, Lin
    Xu, Jun
    Cai, Shaohui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 17636 - 17642
  • [42] Diagnostic value of survivin for malignant pleural effusion: a clinical study and meta-analysis
    Tian, Panwen
    Shen, Yongchun
    Wan, Chun
    Yang, Ting
    An, Jing
    Yi, Qun
    Chen, Lei
    Wang, Tao
    Wang, Ye
    Wen, Fuqiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 5880 - 5887
  • [43] Clinical diagnostic utility of CA 15-3 for the diagnosis of malignant pleural effusion: A meta-analysis
    Wu, Qiang
    Li, Min
    Zhang, Shu
    Chen, Lu
    Gu, Xingting
    Xu, Feng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (01) : 232 - 238
  • [44] Diagnosis and Treatment of Malignant Pleural Effusion A Systematic Literature Review and New Approaches
    Lombardi, Giuseppe
    Zustovich, Fable
    Nicoletto, Maria Ornella
    Donach, Martin
    Artioli, Grazia
    Pastorelli, Davide
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (04): : 420 - 423
  • [45] The diagnostic value of parallel detection of cytokeratin 19 fragment-based tumor markers in malignant pleural effusion: a systematic review and meta-analysis
    Gu, Yan
    Qiao, Xiaojuan
    Wang, Lihong
    Fu, Xiuhua
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (18): : 8105 - 8114
  • [46] Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials
    Wang, Li
    Deng, Huan
    Chen, Xinling
    Li, Can
    Yi, Fengming
    Wei, Yiping
    Zhang, Wenxiong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [47] Efficacy and Safety of Pleural Cryobiopsy vs. Forceps Biopsy for Evaluation of Undiagnosed Pleural Effusion: A Systematic Review and Meta-Analysis
    Giri, Mohan
    Dai, Haiyun
    Guo, Shuliang
    Li, Yishi
    He, Lin
    Zhuang, Rongjuan
    FRONTIERS IN MEDICINE, 2022, 9
  • [48] Systematic review and meta-analysis of vascular endothelial growth factor as a biomarker for malignant pleural effusions
    Fafliora, Eleftheria
    Hatzoglou, Chrissi
    Gourgoulianis, Konstantinos I.
    Zarogiannis, Sotirios G.
    PHYSIOLOGICAL REPORTS, 2016, 4 (24):
  • [49] Diagnostic Accuracy of Combinations of Tumor Markers for Malignant Pleural Effusion: An Updated Meta-Analysis
    Yang, Yuan
    Liu, Ya-Lan
    Shi, Huan-Zhong
    RESPIRATION, 2017, 94 (01) : 62 - 69
  • [50] Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis
    Shen, Yong-Chun
    Liu, Meng-Qi
    Wan, Chun
    Chen, Lei
    Wang, Tao
    Wen, Fu-Qiang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (06) : 1072 - 1076